Noninterventional
OtherNo investigational medicinal products will be administered in this study.
NCT Number: NCT07710846
The purpose of this Patient Identification and Characterization (PIC) study is to collect information and perform limited allergy-related procedures to determine if participants can qualify for cat and/or birch tree pollen allergy clinical research studies in the future. The study is also looking at how cat and/or birch tree pollen allergies have affected overall health.
Trial opening soon.
Get Notified5 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Key Exclusion Criteria:
Note: Other Protocol Defined Inclusion/ Exclusion Criteria Apply
No investigational medicinal products will be administered in this study.
Time frame: At visit 1, up to 30 days
Part A
Time frame: At visit 1, up to 30 days
Part B
Time frame: At visit 1, up to 30 days
Part A
Time frame: At visit 1, up to 30 days
Part B
Contact information is provided by the study sponsor or research team.
Regeneron Pharmaceuticals
Industry
Patient Identification and Characterization (PIC) Study: A Prospective, Multicenter, Non-Interventional Study to Identify and Characterize Participants With Allergic Conjunctivitis With or Without Allergic Rhinitis Due to Cat and/or Birch Allergy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07675811
Allergic Conjunctivitis, Conjunctival Diseases
View Trial DetailsNCT07171307
Conjunctival Diseases, Conjunctivitis
Mexico City, Mexico
View Trial DetailsNCT07138742
Conjunctival Diseases, Conjunctivitis
View Trial DetailsNCT06459219
Allergic Conjunctivitis, Allergic Rhinitis
Vienna, Austria
View Trial Details